MitraClip® therapy in patients with end-stage systolic heart failure.
Standard
MitraClip® therapy in patients with end-stage systolic heart failure. / Franzen, Olaf; van der Heyden, Jan; Baldus, Stephan; Schlüter, Michael; Schillinger, Wolfgang; Butter, Christian; Hoffmann, Rainer; Corti, Roberto; Pedrazzini, Giovanni; Swaans, Martin J; Neuss, Michael; Rudolph, Volker; Sürder, Daniel; Grünenfelder, Jürg; Zu Eulenburg, Christine Gräfin; Reichenspurner, Hermann; Meinertz, Thomas; Auricchio, Angelo.
In: EUR J HEART FAIL, Vol. 13, No. 5, 5, 2011, p. 569-576.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - MitraClip® therapy in patients with end-stage systolic heart failure.
AU - Franzen, Olaf
AU - van der Heyden, Jan
AU - Baldus, Stephan
AU - Schlüter, Michael
AU - Schillinger, Wolfgang
AU - Butter, Christian
AU - Hoffmann, Rainer
AU - Corti, Roberto
AU - Pedrazzini, Giovanni
AU - Swaans, Martin J
AU - Neuss, Michael
AU - Rudolph, Volker
AU - Sürder, Daniel
AU - Grünenfelder, Jürg
AU - Zu Eulenburg, Christine Gräfin
AU - Reichenspurner, Hermann
AU - Meinertz, Thomas
AU - Auricchio, Angelo
PY - 2011
Y1 - 2011
N2 - To assess the feasibility, short-term durability and clinical outcomes of MitraClip® therapy for mitral regurgitation (MR) in patients with end-stage heart failure and a severely reduced left ventricular (LV) ejection fraction.
AB - To assess the feasibility, short-term durability and clinical outcomes of MitraClip® therapy for mitral regurgitation (MR) in patients with end-stage heart failure and a severely reduced left ventricular (LV) ejection fraction.
KW - Comorbidity
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Treatment Outcome
KW - Feasibility Studies
KW - Kaplan-Meier Estimate
KW - Prostheses and Implants
KW - Stroke Volume
KW - Heart Failure/epidemiology/mortality
KW - Mitral Valve Insufficiency/epidemiology/mortality/physiopathology/therapy/ultrasonography
KW - Natriuretic Peptide, Brain/blood
KW - Peptide Fragments/blood
KW - Ventricular Dysfunction, Left/epidemiology
KW - Comorbidity
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Treatment Outcome
KW - Feasibility Studies
KW - Kaplan-Meier Estimate
KW - Prostheses and Implants
KW - Stroke Volume
KW - Heart Failure/epidemiology/mortality
KW - Mitral Valve Insufficiency/epidemiology/mortality/physiopathology/therapy/ultrasonography
KW - Natriuretic Peptide, Brain/blood
KW - Peptide Fragments/blood
KW - Ventricular Dysfunction, Left/epidemiology
M3 - SCORING: Journal article
VL - 13
SP - 569
EP - 576
JO - EUR J HEART FAIL
JF - EUR J HEART FAIL
SN - 1388-9842
IS - 5
M1 - 5
ER -